Illumina
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission-critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina's innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.
Content by Illumina
|5 min read
The Expanding Role of Liquid Biopsy in Oncology
Insight into the strengths, limitations, and clinical utility of liquid biopsy for molecular profiling and residual disease detectionSponsored by
|3 min read
Identify All Relevant Pathogens with Just One Workflow and Easy Analysis
Precision metagenomics offers an efficient and comprehensive approach for characterizing the microbial environmentSponsored by
|1 min read
Transform Your Approach to Infectious Disease Diagnostics with Precision Metagenomics
Download this infographic to see how pathogen detection is improved with precision metagenomics, as compared to traditional and molecular microbiologySponsored by
Available on Demand
Precision Metagenomics for Infectious Disease Testing
Join Today's Clinical Lab and Steve Miller, MD, PhD, to learn about metagenomic next-generation sequencing (mNGS) for the detection of infectious disease pathogensSponsored by
Page 1 of 1
